4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.

      1 , , , ,
      Pediatrics

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Preterm neonates undergoing intensive care have high morbidity from sepsis. These infants also frequently develop neutropenia, and when this is associated with sepsis, mortality is high. This study investigates the potential for granulocyte-macrophage colony-stimulating factor (GM-CSF) to effect a clinically relevant increase in neutrophil number when used prophylactically in high-risk preterm neonates, and assesses its safety in this population.

          Related collections

          Author and article information

          Journal
          Pediatrics
          Pediatrics
          0031-4005
          0031-4005
          Apr 1999
          : 103
          : 4 Pt 1
          Affiliations
          [1 ] Department of Haematology, King's College, St Thomas' Hospital, London,United Kingdom.
          Article
          10103305
          609f3782-1631-4bad-b863-afc1f27eed74
          History

          Comments

          Comment on this article